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STUDY QUESTION: Does CO2 laser vaporization offer better results in treating endometrioma in terms of ovarian reserve preservation
compared to traditional cystectomy?
SUMMARY ANSWER: Assessing both antral follicle count (AFC) and serum anti-Müllerian hormone (AMH) levels as measures of ovarian
reserve, the results suggest that CO2 technology may be an alternative treatment for endometrioma, causing minimal damage to adjacent
healthy ovarian tissue.
WHAT IS KNOWN ALREADY: Excisional surgery has been questioned as an ideal surgical approach for endometriomas because it is
associated with potential reduction of ovarian reserve. Recently, vaporization with CO2 laser in-line-of-sight, according to the ‘three-step pro-
cedure’, has been proposed as the best method to preserve ovarian function. However, no randomized controlled trials have been con-
ducted to compare cystectomy and ‘one-step’ CO2 fiber laser vaporization (without GnRH agonist therapy) with respect to the ovarian
reserve.
STUDY DESIGN, SIZE, DURATION: A multicentre randomized clinical trial including 60 patients was performed between July 2017 and
February 2018. Computerized randomization was conducted to allocate them in a proportion of 1:1 either to Group 1 (laparoscopic strip-
ping: cystectomy) or Group 2 (CO2 laser vaporization). Patients in Group 1 underwent a standardized laparoscopic stripping technique;
patients in Group 2 underwent drainage of the cyst content, biopsy and vaporization of the internal wall with a CO2 fiber laser. Patients
underwent pelvic ultrasound examination to determine the AFC and blood sampling to determine AMH levels before surgery and at 1- and
3-month follow-up.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Patients undergoing surgery for symptomatic endometriomas (infertility and/
or pelvic pain) larger than 3 cm were randomized in two groups according to the surgical technique. Patients aged ≥40 years, or with deep
infiltrating endometriosis/adenomyosis, or previously submitted to surgical procedures on the ovaries or to hysterectomy were excluded
from the study. The primary endpoint was the comparison of intra-group AFC changes before and after surgery (ΔAFC) between the two
groups (ΔAFC Group 1 versus ΔAFC Group 2). The secondary endpoint was the modification of serum AMH before and after surgery
(ΔAMH) between the two groups (ΔAMH Group 1 versus ΔAMH Group 2).
MAIN RESULTS AND THE ROLE OF CHANCE: The AFC of the operated ovary was significantly increased in Group 2 (laser vaporiza-
tion) compared with Group 1 (cystectomy) after surgery (Group 1: from 4.1 ± 2.2 [mean ± SD] at baseline to 6.3 ± 3.5 at 3-month
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follow-up; 95% CI: 0.9–4; Group 2: from 3.6 ± 1.9 at baseline to 8.6 ± 4.2 at 3-month follow-up; 95% CI: 2.8–7.1; P = 0.016); serum AMH
levels were significantly reduced at 3 months in Group 1 (from 2.6 ± 1.4 ng/mL at baseline to 1.8 ± 0.8 ng/mL at 3-month follow-up; 95%
CI: −1.3 to −0.2; P = 0.012) compared with no reduction in Group 2 (from 2.3 ± 1.1 ng/mL at baseline to 1.9 ± 0.9 ng/mL at 3-month fol-
low-up; 95% CI: −1 to −0.2; P = 0.09).
LIMITATIONS, REASON FOR CAUTION: The key limitations of the trial were the low accuracy of AFC in estimating the ovarian reserve
in ovaries with endometriomas, the limited study size and the relatively short follow-up, which do not allow us to draw definitive conclusions.
WIDER IMPLICATIONS OF THE FINDINGS: The present study suggests that CO2 technology may treat endometrioma with minimal
damage to the adjacent healthy ovarian tissue; however, this study should be considered as a preliminary clinical trial, intended to stimulate
future larger trials to address this clinically relevant issue.
STUDY FUNDING/COMPETING INTEREST(S): None.
TRIAL REGISTRATION NUMBER: ClinicalTrials.gov NCT03227640.
TRIAL REGISTRATION DATE: 9 July 2017.
DATE OF FIRST PATIENT’S ENROLLMENT: 24 July 2017.
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Introduction
The most appropriate treatment of endometrioma has been ques-
tioned for a long time and is still controversial. Excision of the cyst cap-
sule with the stripping technique (cystectomy) seems to be more
beneficial than drainage and ablative techniques since it provides a
higher spontaneous pregnancy rate and lower recurrence rate
(Dunselman et al., 2014). Recently, however, some concerns have
been raised as to the possibility that surgical excision of the endome-
trioma may negatively impact on the ovarian reserve of the operated
ovary; this effect is thought to be related to excessive removal and
thermal destruction of healthy ovarian tissue with subsequent loss of
ovarian follicles (Busacca et al., 2006; Benaglia et al., 2010). According
to a recent report, absence of follicular growth was observed in 13%
of operated ovaries, although this event never occurred in the contra-
lateral gonad (Benaglia et al., 2010). Moreover, poorer responses to
gonadotrophin stimulation for IVF have been reported for ovaries fol-
lowing excisional surgery (Somigliana et al., 2003).
In our Institutions, concerns about ovarian failure after cystectomy
resulted in the introduction of an ablative technique involving CO2
laser technology, which has the ability to deliver energy with little ther-
mal spread, unlike other energy sources such as diathermy. It provides
a precise tissue dissection, ablation, controlled depth of tissue penetra-
tion and thermal damage; for these reasons, endometrioma ablation
using laser energy may represent a less destructive approach towards
the healthy ovarian cortex compared to other energy sources (e.g.
electrocoagulation). This surgical procedure was inspired by the one
employed by Jacques Donnez for more than 20 years in which a CO2
laser was used to ablate the endometrioma inner wall, after 3 months
of GnRH agonist (GnRHa) therapy (Donnez et al., 1996). Laser vapor-
ization, according to the ‘three-step procedure’, has also been pro-
posed as the best method to preserve ovarian function (Tsolakidis
et al., 2010); moreover, reassuring data on the rate of long-term recur-
rence after laser vaporization have also recently been published
(Carmona et al., 2011).
However, no randomized controlled trials have been conducted to
compare cystectomy and ‘one-step’ CO2 laser vaporization (without
GnRHa therapy) with respect to the ovarian reserve. We previously
showed the benefits of CO2 laser vaporization on ovarian reserve
through a prospective clinical trial assessing the postoperative changes
in ovarian reserve in terms of antral follicle count (AFC) and anti-Müllerian
hormone levels (AMH). The results of this pilot study supported the posi-
tive effects of CO2 laser on ovarian reserve as demonstrated by higher
AFC and no change in AMH levels at 3-month follow-up (Ottolina et al.,
2017). In order to provide additional data about the impact of CO2 laser
ablation versus cystectomy on ovarian reserve, a small randomized trial
was conducted. The aim of this study was to determine whether and to
what extent the two surgical procedures for endometriomas treatment
(cystectomy versus CO2 laser vaporization) may affect ovarian reserve by
comparing changes in sonographic AFC and serum AMH concentrations
after treatment.
Materials andMethods
This multicentre randomized study included patients who underwent sur-
gery for primary unilateral or bilateral symptomatic endometriomas at two
study centers: San Raffaele Scientific Institute in Milan, Italy and Jagiellonian
University Medical College, Cracow, Poland.
Owing to a lack of relevant literature, we initially calculated an estimated
population of 100 patients based on the study by Pados et al. (2010), inves-
tigating the impact of cystectomy and vaporization with CO2 laser in-line-
of-sight according to the ‘three-step procedure’ on sonographic indicators
of ovarian reserve. In the meantime, a case series with the aim to assess
the postoperative changes of ovarian reserve using the ‘one-step’ fiber
laser procedure (Ottolina et al., 2017) was conducted in our Center and
results became available just before starting to recruit patients for the ran-
domized study. We therefore decided to base the power calculation of
the randomized trial on the findings from our own pilot study. In this case
series, a postoperative AFC of 8.1 ± 5.1 after surgical treatment with CO2
fiber laser was reported. Based on these data, the number of subjects to
be enrolled was calculated arbitrarily, assuming a difference of 4.05 in the
number of postoperative AFC between the two groups as clinically rele-
vant (this corresponds to a 50% difference when compared to the post-
operative AFC observed in the laser group of the pilot study). We set a
probability of type I error equal to 0.05, a power of 80% and assumed the
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same basal AFC count and standard deviation in the two study groups.
We calculated that a sample size of 26 patients per group was needed.
Taking into account protocol deviations and withdrawal of consent, we
established 30 patients per group to undergo randomization.
The inclusion criteria were: symptomatic (pain and/or infertility) patients of
reproductive age; primary unilateral or bilateral endometriomas; largest diam-
eter of the endometrioma ≥3 and ≤8 cm. The diameter cutoff was chosen
according to previous data present in the literature and guidelines for the man-
agement of endometriomas (Dunselman et al., 2014).
The exclusion criteria were: patients aged ≥40 years; detection of deep
infiltrating endometriosis at pre-operative work-up; evidence of adeno-
myosis at the pre-operative ultrasound; previous surgical procedures on
the ovaries; unilateral oophorectomy; previous salpingectomy or hysterec-
tomy; other endocrine diseases such as thyroid disease; hormonal treat-
ment within 3 months of ovarian reserve assessment.
Patients fitting the above inclusion criteria and consenting to partici-
pate were randomly assigned according to a computer-generated ran-
domization list generated using the method of simple randomization to
allocate them in proportion, at 1:1, either to Group 1 (laparoscopic
stripping: cystectomy) or Group 2 (laser vaporization). Randomization
assignments were placed into sealed, numbered, opaque envelopes that
were opened sequentially once a patient had given her consent to par-
ticipate. Randomization was assigned by a study co-ordinator (at San
Raffaele Scientific Institute) who had no other role in the study.
Operative laparoscopy was performed by a team of surgeons with
extensive experience in the treatment of endometriosis (M.C., S.F., E.P.,
R.J.), during the proliferative phase of the menstrual cycle.
Patients in Group 1 underwent a standardized laparoscopic stripping
technique to treat endometriomas.
Patients in Group 2 underwent drainage of the cyst content, irrigation
and inspection of its inner wall. A biopsy of the cyst wall was sent for rou-
tine histologic examination to confirm the diagnosis of endometriosis.
When possible, the cyst was everted in order to expose the inner cystic
wall completely. After that, the cystic lining was completely vaporized with
CO2 fiber laser (UltraPulse Duo system, Lumenis Ltd, Yokneam, Israel) in
a radial way starting from the center to the periphery, at a power density
of 13W/cm2. No suture was placed after vaporization.
In all patients, the diagnosis of endometrioma was confirmed by surgical
exploration and histopathologic examination. Endometriosis was staged
according to the revised American Society for Reproductive Medicine clas-
sification (American Society for Reproductive Medicine, 1997).
Within the month before surgery, patients underwent a gynecologic
examination with pelvic ultrasound during the proliferative phase to deter-
mine the AFC, and blood samples were taken to determine AMH levels
(AMH Gen II ELISA, Beckman Coulter Life Sciences, Indiana, USA) at base-
line. Afterwards, at 1 and 3 months after surgery, both AFC and AMH
levels were re-evaluated. Patients were then referred to the Endometriosis
Outpatient Clinic for further follow-up.
The AFC was assessed by counting the number of follicles with an aver-
age diameter of 2–10 mm in both ovaries; the AFC of the operated ovary
and the AFC of both ovaries were recorded. During ultrasound examin-
ation, the volume of each ovary (at baseline, and 1 and 3 months after sur-
gery) and endometrioma, expressed in cm3, was also assessed using the
Prolate ellipsoid formula: volume = 0.5233 × D1 (longitudinal) × D2
(transverse) × D3 (anterior–posterior). In addition, the largest diameter of
the endometrioma was recorded. Pelvic ultrasound was performed by an
experienced ultrasonographer who remained blinded to the type of surgi-
cal procedure, at each center (J.O., A.N.). A test of the intraobserver
reproducibility for AFC assessment was performed (intraclass correlation
coefficient = 0.91, 95% CI: 0.85–0.96).
Total operative time, operative time required to treat endometriomas,
estimated blood loss, intraoperative/postoperative complications, length of
hospitalization and postoperative evolution of symptoms were recorded.
The primary endpoint was the comparison of the AFC changes after
treatment between the two groups. The secondary endpoint was the
evaluation of serum AMH modifications before and after treatment
between the two groups. We set the change in AFC as the primary out-
come of the study since it has the advantage, unlike AMH, of showing the
ovarian reserve of a single ovary: the validity of AMH is still debated
because the relative contribution of the affected and intact ovaries cannot
be definitely discriminated.
The study protocol was reviewed and approved by the Review Boards
of participating Institutions before enrollment of the first patient (protocol
No.: LASER-LUM). The study was conducted in compliance with the
Declaration of Helsinki, as outlined in the International Conference on
Harmonization Guidelines for Good Clinical Practice, and applicable regu-
latory requirements (Trial Registration: ClinicalTrials.gov NCT03227640).
All the participating patients provided written informed consent before
enrollment into the study.
Statistical analysis
The normal distribution of continuous variables was evaluated with the
Kolmogorov–Smirnov test. Categorical variables were compared by Chi
square test and Fisher’s exact test. Continuous variables between the
study groups were compared using Student’s t-test, while non-parametric
variables were compared using Mann–Whitney test according to data dis-
tribution. Linear regression analysis was conducted in order to compare
differences between AFC of the operated ovary, AMH levels and ovarian
volume at baseline and at 3-month follow-up between the two groups
(ΔAFC Group 1 versus ΔAFC Group 2; ΔAMH Group 1 versus ΔAMH
Group 2; Δ ovarian volume Group 1 and Δ ovarian volume Group 2),
adjusting for patients’ age.
Statistical calculations were performed using the Statistical Package for
the Social Sciences version 21.0 (SPSS, Chicago, IL, USA). A P < 0.05 was
considered statistically significant.
Results
Between July 2017 and November 2017, 60 women fulfilled the inclu-
sion criteria for the study, agreed to participate, and completed the
study (Fig. 1).
The baseline clinical characteristics and ultrasonographic findings of
the two study groups are reported in Table I. In particular, there were
bilateral endometriomas in three cases in Group 1 and in six cases in
Group 2, and these were operated with the same technique (cystec-
tomy or CO2 laser vaporization) as the contralateral ovary. Also in
bilateral endometriomas, baseline characteristics were similar between
the two groups.
The operative time, length of hospitalization, follow-up time and
postoperative evolution of symptoms are listed in Table II.
ΔAFC of the operated ovary (at baseline and after 3 months) was
found to be significantly higher (adjusted P = 0.016, B coeff. = 3 .41) in
Group 2 (from 3.6 ± 1.9 at baseline to 8.6 ± 4.2 at 3-month follow-
up; 95% CI: 2.8–7.1) compared with Group 1 (from 4.1 ± 2.2 at base-
line to 6.3 ± 3.5 at 3-month follow-up; 95% CI: 0.9–4). No differences
emerged from the analysis of ΔAFC of the non-operated ovary (base-
line and after 3 months) between the two groups (adjusted P = 0.43)
(data not shown).
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A significant difference (adjusted P = 0.006, B coeff. = −0.11)
regarding Δ serum AMH concentrations (at baseline and after 3
months) was observed between the two groups (Group 1: from 2.6 ±
1.4 ng/mL at baseline to 1.8 ± 0.8 ng/mL at 3-month follow-up; 95%
CI: −1.3 to −0.2; Group 2: from 2.3 ± 1.1 ng/mL at baseline to 1.9 ±
0.9 ng/mL at 3-month follow-up; 95% CI: −1 to −0.2).
In the case of bilateral endometriomas, no significant differences
emerged in ΔAFC (baseline and after 3 months) between Group 1
(from 3.5 at baseline to 11 at 3-month follow-up) and Group 2 (from
9.8 at baseline to 15.1 at 3-month follow-up) nor inΔAMH levels (base-
line and after 3 months) between the two groups (adjusted P = 0.43).
Comparison of ultrasonographic findings for AFC and serum hormo-
nal concentrations between the two groups before and 3 months after
treatment are presented in Table III.
After cyst wall removal in Group 2, ovarian volume was similar in
the operated ovary and in the contralateral non-operated ovary
(7.9 ± 2.8 cm3 and 8.7 ± 3.4 cm3; P = 0.3); in Group 1, ovarian vol-
ume of the operated ovary was smaller when compared with that
of the contralateral non-operated ovary (5.5 ± 2.4 and 7.8 ±
3.5 cm3; P = 0.019). A linear regression analysis showed a significant
difference regarding Δ ovarian volume (operated ovary and contra-
lateral non-operated ovary) between the two groups (adjusted P =
0.020, B coeff. = 2.1).
........................................................................................
Table I Baseline clinical characteristics and
ultrasonographic findings of the two groups of patients
with ovarian endometrioma.
Characteristics Cystectomy
Group 1
(n = 30)
CO2 laser
vaporization
Group 2 (n = 30)
Age (years) 30.3 ± 5.2 32.1 ± 4.8
Indications for surgery
Dysmenorrhea 12 (40) 13 (43.3)
Chronic pelvic pain 18 (60) 16 (53.3)
Dyspareunia 5 (16.7) 4 (13.3)
Infertility 10 (33.3) 11 (36.7)
Pregnancy desire 19 (63.3) 17 (56.7)
BMI (kg/m2) 21.8 ± 2.3 20.7 ± 2.9
Diameter of the cyst 4.9 ± 1.5 4.7 ± 1.4
Bilateral endometrioma 3 (10) 6 (20)
Endometriomas in right ovary 15 (50) 15 (50)
Endometriomas in left ovary 18 (60) 21 (70)
Values are mean±SD or n (%).
Figure 1 Flow chart of participants from recruitment to follow-up in a study of ovarian reserve after cystectomy versus CO2 laser vaporization in
the treatment of ovarian endometrioma.
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No intraoperative or postoperative complications were reported.
No recurrences of endometrioma were reported at a mean follow-up
of 7.2 months (range: 6–10).
In this series, 25 patients (41.7%) wished to become pregnant and,
following the surgeon’s advice, were allowed to attempt a spontan-
eous conception after surgery (Group 1: n = 13 (43.3%); Group 2: n =
12 (40%), P = 0.09). At a mean follow-up of 5.3 months, two patients
(15.4%) in Group 1 and three patients (25%) in Group 2 were preg-
nant. Eleven patients (Group 1: n = 3; Group 2: n = 8) who were
operated because they were symptomatic, were referred to IVF
(ongoing) at the end of the 3-month follow-up, considering their age
>37 years and the baseline levels of AMH.
The remaining patients who had no immediate pregnancy intention,
received medical therapy (estroprogestins) at the end of the study.
Discussion
The present study is the first, although small, randomized trial that
compares cystectomy to ‘one-step’ CO2 fiber laser vaporization for
the management of endometriomas and assesses the impact of both
techniques on ovarian reserve. Our results suggest that ablation with
CO2 laser technology is associated with a more significant increase in
the AFC of the operated ovary compared to the values observed after
cystectomy. Our study is supported by previous ones suggesting that
endometrioma ablation using energies with minor in depth thermal
spread, such as CO2 laser and plasma energy, may represent an effect-
ive ovarian tissue-sparing technique (Canis et al., 2001; Tsolakidis
et al., 2010; Var et al., 2011; Roman et al., 2013). Increasing evidence
exists about the risk of reducing ovarian reserve following cystectomy
because of the inadvertent removal of healthy ovarian cortex together
with the endometrioma wall, and the amount of ovarian tissue
removed inversely correlates to the level of surgical expertise and dir-
ectly correlates to the cyst size (Muzii et al., 2007, 2011; Roman et al.,
2010).
Nevertheless, a large majority of surgeons abandoned ablative tech-
niques after a 2008 Cochrane review (Hart et al., 2008) reporting bet-
ter outcomes with stripping techniques with respect to cyst ablation in
terms of recurrence of endometrioma and spontaneous pregnancy
rates. However, based on only three older randomized trials, the valid-
ity of this Cochrane review has been questioned, especially as the abla-
tion group consisted of bipolar energy only, which is most likely
responsible for a deeper thermal effect, not taking into account results
from CO2 laser or plasma energy studies, which have a low thermal
spread (Daniell et al., 1991; Donnez et al., 1996, 2004; Sutton and
Jones, 2002; Roman et al., 2011).
There are consistent data in the literature about the safety and effi-
cacy of CO2 laser technology: according to Donnez et al. (2001), abla-
tion cannot penetrate into the tissue by more than 1.0–1.5 mm.
.............................................................................................................................................................................................
Table II Surgical characteristics and follow-up of the two groups of patients.
Characteristics Cystectomy Group 1
(n = 30)
CO2 laser vaporization Group 2
(n = 30)
P value
Operative time (min) 56.5 ± 22.3 54.3 ± 21 0.66
Operative time for endometrioma (min) 26.8 ± 8.2 23.2 ± 7.9 0.09
Hospital stay (days) 2.3 ± 0.6 2.4 ± 0.6 0.75
Follow-up (months) 7.8 ± 1.5 8.1 ± 1.4 0.8
Postoperative improvement of dysmenorrhea 11/12 (91.7) 12/13 (92.3) 0.6
Postoperative improvement of chronic pelvic pain 15/18 (83.3) 13/16 (81.3) 0.9
Postoperative improvement of dyspareunia 2/5 (40) 2/4 (50) 0.65
Values are mean±SD or n (%). Data were analyzed using Chi square test, Fisher’s exact test, Student’s t-test and Mann–Whitney test according to variables type and data
distribution.
.............................................................................................................................................................................................
Table III Comparison of the sonographic and serum indicators of ovarian reserve in patients before and 3 months after
surgery.
Variable Cystectomy
(n= 30) Group 1
Baseline
Group 1
Month 3
95% CI P value* CO2 laser
vaporization (n = 30)
Group 2 Baseline
Group 2
Month 3
95% CI P value* Adj.
P value**
AFC 4.1 ± 2.2 6.3 ± 3.5 0.9–4 0.06 3.6 ± 1.9 8.6 ± 4.2 2.8–7.1 <0.001 0.016
Serum AMH
(ng/mL)
2.6 ± 1.4 1.8 ± 0.8 −1.3 – −0.2 0.012 2.3 ± 1.1 1.9 ± 0.9 −1 – −0.2 0.09 0.006
*Intra-group Student’s t-test.
**Linear regression analysis adjusted for patients’ age.
Values are mean ± SD.
AFC = antral follicle count (operated ovary).
AMH = anti-Müllerian hormone.
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Therefore, this technique appears to destroy the filmy superficial
internal lining of the cyst selectively (the glandular epithelium and sub-
jacent stroma), without reaching the fibrotic capsule surrounding the
endometrioma or the adjacent healthy ovarian cortex.
Based on this evidence, since 2015 we have adopted the CO2 fiber
laser for use in the surgical treatment of ovarian endometriosis (with-
out GnRHa therapy before surgery). CO2 fiber laser vaporization may
represent a more advantageous approach than other energy sources
(CO2 laser in-line-of-sight or plasma laser) for several reasons. It is
simple, easy to use and highly reproducible (Vanni et al., 2018), and
thanks to its high precision provides optimal coagulation and ablation
capabilities, minimizing the need for electrocoagulation or suturing.
Thanks to its low thermal energy, it avoids excessive ischemia and
allows safe management of delicate tissues, such as ovarian paren-
chyma. Moreover, the long arm of the flexible fiber allows the surgeon
to reach narrow anatomical spaces, and it can be introduced in the
peritoneal cavity from any laparoscopic access, allowing the surgeon
the optimal approach to the operative field.
We have previously reported the positive effects of CO2 laser on
ovarian reserve in a prospective clinical trial assessing the post-
operative changes in ovarian reserve of 15 patients who had their
endometrioma vaporized with CO2 fiber laser (Ottolina et al., 2017).
The results showed a higher AFC and no change in AMH levels at
3-month follow-up compared to baseline.
In order to provide additional data about the potential advantage of
using CO2 laser ablation over ovarian cystectomy on ovarian reserve,
a randomized trial was conducted. Our results, showing a significant
improvement in the AFC of the operated ovary after CO2 laser vapor-
ization compared to cystectomy, reinforce those of Pados et al. (2010)
who found an increase in AFC in the treated ovary 6 months after the
‘three-stage procedure’ and of Donnez et al. (2010) who reported
AFC values similar to those of the contralateral ovary after using a
combined excisional and ablative technique; however, these studies
have several limitations, i.e. the small sample size and the non-
randomized design of the trial.
We reported a significant decrease in serum AMH levels in the cyst-
ectomy group, whereas no change in AMH levels was found after laser
vaporization; these positive findings are consistent with those reported
by Tsolakidis et al. (2010) and could be related to CO2 laser technol-
ogy; however, differences between ΔAMH may be considered too
small to be clinically relevant. Moreover, in patients randomized to
laser vaporization, we have demonstrated similar ovarian volumes
between the operated ovary and the contralateral non-operated
ovary. These results support other published data (Donnez et al.,
2010), and suggest a possible role of CO2 laser in preserving a normal
ovarian volume.
No recurrences of endometriomas were reported in either group,
even though no definitive conclusion can be drawn due to the short-
term follow-up. However, reassuring data on the rate of long-term
recurrence after laser vaporization have also recently been published:
Carmona and his colleagues reported a statistically significant increase
in short-term recurrence rates in patients undergoing laser treatment
compared to cystectomy; however, no statistically significant differ-
ences in long-term (5 years) recurrence rates were found between
cystectomy and CO2 laser vaporization (Carmona et al., 2011).
However, this study has several weaknesses. The major limitation is
represented by the use of AFC in estimating the ovarian reserve in
ovaries with endometriomas. The presence of a large endometrioma
may impair the sonographic identification of small follicles adjacent to
the cyst and, consequently, ovarian reserve could be underestimated
before surgery. This could be the reason why the AFC of the operated
ovary has been shown to increase in both groups after treatment.
However, besides AFC changes after surgery, AMH levels have also
been analyzed. No significant differences emerged in AMH levels
before and after laser vaporization, whereas serum AMH levels were
significantly reduced after cystectomy. Therefore, CO2 laser may have
less harmful effects on the ovarian tissue compared to cystectomy.
Moreover, the sample size is small, thus estimation of results may be
less precise. This is a small randomized trial with sufficient statistical
power to detect only large differences in primary endpoint between
the two groups. It should be pointed out that a larger population
would allow a more precise estimation of difference in primary end-
point between the two groups of treatment. Therefore, the present
study should be considered as a preliminary clinical trial where the
number of patients recruited was probably small from a biometric
point of view, but it is intended to stimulate future larger trials to
address this clinically relevant issue.
Another limitation of the study is the relatively short follow-up and
the subsequent inability to measure a conclusive pregnancy rate.
However, some authors suggested that the traumatic damage inflicted
to the ovarian cortex following endometrioma surgery is immediate
and a recovery is possible in the early postoperative period (as early as
3 months after surgery), when edema and local inflammation end
(Chang et al., 2010; Roman et al., 2014). For this reason, we con-
sidered 3-month follow-up as an optimal time to evaluate the ovarian
reserve. Moreover, pregnancy rate was not within the outcomes we
set for this study.
In conclusion, this study suggests that CO2 fiber laser may treat
endometrioma with minimal damage to the adjacent healthy ovarian
tissue. Additional well-designed trials are needed to verify changes in
AFC and AMH at a longer follow-up and to address the fertility
outcomes.
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